Publication | Open Access
Lenalidomide improves the antitumor activity of CAR-T cells directed toward the intracellular Wilms Tumor 1 antigen
16
Citations
19
References
2021
Year
These results demonstrate that lenalidomide potentiates WT1 CAR-T activity and paves the way to evaluate the combination of LEN with CAR-T for a planned clinical trial.
| Year | Citations | |
|---|---|---|
Page 1
Page 1